46
Views
16
CrossRef citations to date
0
Altmetric
Original Article

Rheumatoid Arthritis and Tumor Necrosis Factor α

&
Pages 291-303 | Received 30 Aug 2000, Accepted 14 Feb 2001, Published online: 07 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Abdullah Alghasham & Zafar Rasheed. (2014) Therapeutic targets for rheumatoid arthritis: Progress and promises. Autoimmunity 47:2, pages 77-94.
Read now
Qian Wu, Qingrui Yang, Hongsheng Sun, Ming Li, Yuanchao Zhang & Antonio La Cava. (2013) Serum IFN-λ1 is abnormally elevated in rheumatoid arthritis patients. Autoimmunity 46:1, pages 40-43.
Read now
Tsutomu Takeuchi, Kensei Tsuzaka, Thoru Abe, Keiko Yoshimoto, Kiyono Shiraishi, Hideto Kameda & Kouichi Amano. (2005) T cell abnormalities in systemic lupus erythematosus. Autoimmunity 38:5, pages 339-346.
Read now
TSUTOMU TAKEUCHI, KENSEI TSUZAKA & TOHRU ABE. (2004) ALTERED EXPRESSION OF THE T CELL RECEPTOR-CD3 COMPLEX IN SYSTEMIC LUPUS ERYTHEMATOSUS. International Reviews of Immunology 23:3-4, pages 273-291.
Read now

Articles from other publishers (12)

Swati Chadha, Tapan Behl, Simona Bungau, Arun Kumar, Rashmi Arora, Amit Gupta, Md Sahab Uddin, Gokhan Zengin, Lotfi Aleya, Dhruv Setia & Sandeep Arora. (2020) Mechanistic insights into the role of pyroptosis in rheumatoid arthritis. Current Research in Translational Medicine 68:4, pages 151-158.
Crossref
Klementy Shchetynsky, Lina-Marcella Diaz-Gallo, Lasse Folkersen, Aase Haj Hensvold, Anca Irinel Catrina, Louise Berg, Lars Klareskog & Leonid Padyukov. (2017) Discovery of new candidate genes for rheumatoid arthritis through integration of genetic association data with expression pathway analysis. Arthritis Research & Therapy 19:1.
Crossref
Qiong-jie Chang, Cheng Lv, Feng Zhao, Ting-shuang Xu & Ping Li. (2017) Elevated Serum Levels of Interleukin-29 Are Associated with Disease Activity in Rheumatoid Arthritis Patients with Anti-Cyclic Citrullinated Peptide Antibodies. The Tohoku Journal of Experimental Medicine 241:2, pages 89-95.
Crossref
Jun Wang, Yuxuan Du, Hongyan Qian, Haitao Yu, Shentao Li, Xulong Zhang, Zhanguo Li, Huihui Yuan & Wenming Zhao. (2014) Engineering and characterization of a humanized antibody targeting TNF-α and RANKL. Biochemical and Biophysical Research Communications 450:1, pages 717-722.
Crossref
Huihui Yuan, Hongyan Qian, Sibo Liu, Xulong Zhang, Shentao Li, Wei Wang, Zhanguo Li, Junhui Jia & Wenming Zhao. (2012) Therapeutic role of a vaccine targeting RANKL and TNF-α on collagen-induced arthritis. Biomaterials 33:32, pages 8177-8185.
Crossref
Nádia Emi Aikawa, Jozélio Freire de Carvalho, Clovis Artur Almeida Silva & Eloísa Bonfá. (2009) Immunogenicity of Anti-TNF-α Agents in Autoimmune Diseases. Clinical Reviews in Allergy & Immunology 38:2-3, pages 82-89.
Crossref
Tsutomu Takeuchi. (2009) Present Status and Problems in Biologics for Treatment of Rheumatoid Arthritis in Japan日本における関節リウマチに対する生物学的製剤の現状と問題点. Nihon Naika Gakkai Zasshi 98:4, pages 883-889.
Crossref
Hongbin Song, Fei Qiao, Carl Atkinson, V. Michael Holers & Stephen Tomlinson. (2007) A Complement C3 Inhibitor Specifically Targeted to Sites of Complement Activation Effectively Ameliorates Collagen-Induced Arthritis in DBA/1J Mice. The Journal of Immunology 179:11, pages 7860-7867.
Crossref
Guangwu Xu & Yufang Shi. (2007) Apoptosis signaling pathways and lymphocyte homeostasis. Cell Research 17:9, pages 759-771.
Crossref
. (2006) Therapy of inflammatory immune diseases. 3) Anti-TNF therapy for articular rheumatism炎症性免疫疾患の治療  3)関節リウマチに対するTNF阻害療法. Nihon Naika Gakkai Zasshi 95:9, pages 1787-1794.
Crossref
Tsutomu Takeuchi, Kouichi Amano, Hideto Kameda & Toru Abe. (2005) Anti-TNF Biological Agents in Rheumatoid Arthritis and Other Inflammatory Diseases. Allergology International 54:2, pages 191-202.
Crossref
Tsutomu YAKEUCHI & Kouichi AMANO. (2004) Anti-TNF therapy in rheumor arthritis新しい生物学的製剤を用いた難治性免疫疾患の治療  TNF阻害による関節リウマチの治療. Japanese Journal of Clinical Immunology 27:1, pages 7-15.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.